Literature DB >> 18486285

Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

Paul Henri Lambert1, Philippe E Laurent.   

Abstract

There has been a recent resurgence of interest in intradermal vaccine delivery. The physiological advantages of intradermal vaccine delivery have been known for some time, but the difficulties associated with performing an intradermal injection have historically limited its use. New delivery systems currently in development facilitate convenient intradermal vaccination, unlocking the potential advantages of this delivery route, and potentially transforming vaccine delivery.

Mesh：

Substances：

Year:  2008        PMID： 18486285     DOI： 10.1016/j.vaccine.2008.03.095

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  95 in total

Review 1.  Inactivated influenza vaccines: recent progress and implications for the elderly.

Authors:  Valentina Parodi; Daniela de Florentiis; Mariano Martini; Filippo Ansaldi
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

Review 2.  [Immunosenescence and vaccinations in the elderly].

Authors:  Hans Joachim Hutt; Petra Bennerscheidt; Britta Thiel; Manuela Arand
Journal:  Med Klin (Munich)       Date:  2010-12-07

3.  Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.

Authors:  Laura Goodliffe; Brenda L Coleman; Allison J McGeer
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

4.  Induction of mucosal immunity through systemic immunization: Phantom or reality?

Authors:  Fei Su; Girishchandra B Patel; Songhua Hu; Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

Review 5.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

6.  Intradermal delivery of vaccines: potential benefits and current challenges.

Authors:  J K Hickling; K R Jones; M Friede; D Zehrung; D Chen; D Kristensen
Journal:  Bull World Health Organ       Date:  2011-01-05       Impact factor: 9.408

7.  Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs.

Authors:  Alfred J Harvey; Scott A Kaestner; Diane E Sutter; Noel G Harvey; John A Mikszta; Ronald J Pettis
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

Review 8.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

9.  Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.

Authors:  Pierre Van Damme; Robert Arnou; Froukje Kafeja; Anne Fiquet; Patrick Richard; Stéphane Thomas; Gilles Meghlaoui; Sandrine Isabelle Samson; Emilio Ledesma
Journal:  BMC Infect Dis       Date:  2010-05-26       Impact factor: 3.090

10.  Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.

Authors:  Marc Pearton; Sang-Moo Kang; Jae-Min Song; Alexander V Anstey; Matthew Ivory; Richard W Compans; James C Birchall
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.